Stenting And Thrombectomy Systems Fuel Neuro Device Market Growth
Executive Summary
Advances in distally protected carotid artery stenting systems and second-generation cerebral thrombectomy devices will help drive strong growth in the US neurointerventional device market over the next five years. The market, which includes endovascular devices for the treatment of cerebral aneurysms, arteriovenous malformations, stroke, and carotid artery disease, is projected to grow at a compound annual rate of 6.5%, and reach more than $846 million by 2018.
You may also be interested in...
FDA Clarifies Software Link In Abbott COVID-19 Lab Test Recall
The recall is related to the software’s mixing parameters, which may cause false positives if test samples contaminate each other.
Positive Signs For Valneva’s COVID-19 Vaccine, But Efficacy Data And Orders Still Lacking
Immunogenicity data from Valneva’s COV-COMPARE study are encouraging, but the inactivated vaccine will need proper efficacy data to gain a toehold in a crowded market.
Q3 Review: Editor’s Picks Of Scrip's Top Stories
From the latest COVID-19 advances to the emergence of game changer for heart failure, Scrip’s editor in chief Eleanor Malone reviews the big stories of the past three months. Safety issues around JAK inhibitors and AAV vector-based gene therapy were also to the fore, while biopharma financing continued apace.